1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NOVO NORDISK - ADR
43.88 1.66 (3.93%)
26.2M
XNYS Volume

XNYS 01 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Novo Nordisk (ADR) is on 07 May 2026 for the purpose of Novo Nordisk AS First Quarter Earnings Results for 2026 See details

Novo Nordisk (ADR) - NVO - stock price prediction, stock price target, analyst ratings from 14 analysts

Novo Nordisk (ADR) has a share price target of US$ 47, revenue growth forecast of -7.2%, and profit growth estimate of -7.7% for FY26, based on top 14 analyst calls.